Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Ying Fan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
International Journal of Cancer|December 7, 2020
Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screeningGeng-Hang Chen, Zhiwei Liu, Ming-Fang Ji, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Clinical Chemistry|March 24, 2022
Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening ProgramsGeng Hang Chen, Zhiwei Liu, Kelly J Yu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
BMC Cancer|February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRTShan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
International Journal of Cancer|December 7, 2020
Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screeningGeng-Hang Chen, Zhiwei Liu, Ming-Fang Ji, et al.
Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.
Clinical Chemistry|March 24, 2022
Utility of Epstein-Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening ProgramsGeng Hang Chen, Zhiwei Liu, Kelly J Yu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
BMC Cancer|February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRTShan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Pageof 4